Aquatic Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History

Aquatic Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $743,125 - $896,875	-20,500 Reduced 83.0%	4,200 $163,000
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $221,831 - $260,208	5,200 Added 26.67%	24,700 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $120,540 - $195,132	4,200 Added 27.45%	19,500 $898,000
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $522,647 - $607,869	15,300 New	15,300 $523,000
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $66,920 - $80,700	2,000 New	2,000 $72,000
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $10,176 - $14,063	-400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $125,450 - $165,650	-5,000 Reduced 92.59%	400 $12,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $84,240 - $191,160	5,400 New	5,400 $169,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.